G
George J. Hruza
Researcher at Saint Louis University
Publications - 280
Citations - 4163
George J. Hruza is an academic researcher from Saint Louis University. The author has contributed to research in topics: Mohs surgery & Skin cancer. The author has an hindex of 28, co-authored 270 publications receiving 3076 citations. Previous affiliations of George J. Hruza include Beth Israel Deaconess Medical Center & Harvard University.
Papers
More filters
Journal ArticleDOI
Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases.
Devon E. McMahon,Erin Amerson,Misha Rosenbach,Jules B. Lipoff,Danna Moustafa,Anisha Tyagi,Seemal R. Desai,Lars E. French,Lars E. French,Henry W. Lim,Bruce H. Thiers,George J. Hruza,Kimberly G. Blumenthal,Lindy P. Fox,Esther E. Freeman +14 more
TL;DR: In this article, a provider-facing registry-based study collected cases of cutaneous manifestations after COVID-19 vaccination and found that delayed large local reactions were most common, followed by local injection site reactions, urticarial eruptions, and morbilliform eruptions.
Journal ArticleDOI
AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery
Suzanne M. Connolly,Diane Baker,Brett M. Coldiron,Michael J. Fazio,Paul A. Storrs,Allison T. Vidimos,Mark J. Zalla,Jerry D. Brewer,Wendy Smith Begolka,Timothy G. Berger,Michael Bigby,Jean L. Bolognia,David G. Brodland,Scott A.B. Collins,Terrence A. Cronin,Mark V. Dahl,Jane M. Grant-Kels,C. William Hanke,George J. Hruza,William D. James,Clifford W. Lober,Elizabeth I. McBurney,Scott A. Norton,Randall K. Roenigk,Ronald G. Wheeland,Oliver J. Wisco +25 more
TL;DR: The appropriate use criteria process synthesizes evidence-based medicine, clinical practice experience, and expert judgment to optimize the use of MMS for scenarios in which the expected clinical benefit is anticipated to be the greatest.
Journal ArticleDOI
Selective photothermolysis of cutaneous pigmentation by Q-switched Nd: YAG laser pulses at 1064, 532, and 355 nm.
R. Rox Anderson,Randall J. Margolis,Shinichi Watenabe,Thomas J. Flotte,George J. Hruza,Jeffrey S. Dover +5 more
TL;DR: The action spectrum for threshold response was consistent with mechanisms implied by selective photothermolysis, and may be useful for consideration of treatment for cutaneous pigmentation abnormalities or unwanted follicular pigmentation, or both.
Journal ArticleDOI
The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries.
Esther E. Freeman,Devon E. McMahon,Jules B. Lipoff,Misha Rosenbach,Carrie L. Kovarik,Seemal R. Desai,Joanna Harp,Junko Takeshita,Lars E. French,Lars E. French,Henry W. Lim,Bruce H. Thiers,George J. Hruza,Lindy P. Fox +13 more
TL;DR: This study highlights the array of cutaneous manifestations associated with COVID-19, finding that many morphologies were non-specific, while others may provide insight into potential immune or inflammatory pathways in CO VID-19 pathophysiology.
Journal ArticleDOI
Pigmented guinea pig skin irradiated with Q-switched ruby laser pulses. Morphologic and histologic findings
Jeffrey S. Dover,Randall J. Margolis,Luigi L. Polla,Shinichi Watanabe,George J. Hruza,John A. Parrish,R. Rox Anderson +6 more
TL;DR: It is demonstrated that selective melanosomal disruption caused by Q-switched ruby laser pulses leads to transient cutaneous depigmentation and persistent follicular depIGmentation and potential exists for selective treatment of pigmented epidermal and dermal lesions with this modality.